Agricultural biotechnology continues to attract growing investment as researchers and startups explore new ways to improve crop productivity and resilience in response to global food security challenges. In this context, Cytotrait, a biotechnology company spun out of The University of Manchester, has secured £3 million in seed funding to accelerate the development of technologies aimed at enhancing crop traits and supporting more sustainable agricultural systems.
The funding round was led by Northern Gritstone, a venture firm focused on commercialising scientific innovation from universities in northern England. Additional participation came from the UK Innovation and Science Seed Fund managed by Future Planet Capital and the Northern Universities Ventures Fund managed by Parkwalk in collaboration with Northern Gritstone.
The newly raised capital will support Cytotrait’s research programmes and help advance its proprietary technology platform designed to introduce and modify genes within plant organelles.
Advancing crop trait engineering
Cytotrait is focused on developing technologies that allow scientists to engineer new plant traits more efficiently. Improving crop genetics has long been a key focus for agricultural researchers seeking to increase yields, strengthen resistance to pests and diseases and improve nutritional or functional characteristics of food crops.
However, traditional plant genetic engineering methods often face technical challenges, particularly when attempting to introduce genetic changes into specific cellular components known as organelles. Organelles such as chloroplasts and mitochondria play critical roles in plant metabolism and energy production, yet modifying their genetic material has historically been difficult.
Cytotrait aims to overcome these barriers with its proprietary technology platform known as MOSS, short for Mutant Organelle Selection System. The platform enables the introduction of genes and gene edits directly into plant organelles, providing a new approach to plant genetic engineering.
Introducing the MOSS technology platform
The company’s MOSS system is designed to allow researchers to achieve homoplasmy more rapidly during the engineering process. Homoplasmy refers to a condition in which all copies of organelle DNA within a cell contain the desired genetic modification.
Achieving homoplasmy is an important step in ensuring that genetic changes remain stable and consistent throughout plant development. Traditional approaches can take considerable time and effort to reach this stage, but Cytotrait’s technology is intended to accelerate the process.
The platform can support both endogenous gene editing and the introduction of new genes into plant organelles. This flexibility allows scientists to modify existing plant genes or introduce entirely new traits that could benefit agricultural production and food systems.
By enabling more precise genetic modifications within chloroplasts and mitochondria, Cytotrait hopes to unlock new possibilities for crop development that were previously difficult to achieve.
Potential applications in agriculture and food production
Cytotrait’s technology has a wide range of potential applications across the agriculture and food industries. One key focus area is improving crop yield, which remains essential as global populations continue to grow and food demand increases.
The platform may also help scientists develop crops that are more resistant to pests and diseases, reducing reliance on chemical pesticides and improving agricultural sustainability.
Another area of interest involves hybrid crop development. Genetic modifications within organelles could enable more efficient breeding of hybrid plants with desirable characteristics such as improved productivity or environmental resilience.
Beyond agricultural productivity, the technology may also support the development of new food related traits. These could include improvements in nutritional content, processing characteristics or other features important for food manufacturers and consumers.
Researchers are also exploring how organelle engineering could contribute to climate related goals. For example, modifying plant metabolism could potentially enhance carbon capture capabilities within crops, supporting broader efforts to reduce greenhouse gas emissions in agriculture.
Expanding research programmes
With the new funding in place, Cytotrait plans to expand its research programmes across several key crops including wheat, maize, potato and canola. These crops play major roles in global agriculture and are widely cultivated across Europe and North America.
The company intends to apply the MOSS platform to explore improvements in crop yield, resilience and sustainability across these species. The research will also examine how the technology could support the development of new food traits and agricultural systems that reduce environmental impact.
As investment in agricultural biotechnology continues to grow, Cytotrait is positioning its organelle engineering technology as a tool that could open new frontiers in crop science. By enabling more precise and efficient genetic modifications, the company aims to support the creation of crops capable of meeting the evolving demands of global food production.
